S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$32.97
-0.4%
$35.64
$19.13
$39.81
$1.24B1.32256,682 shs214,906 shs
Eargo, Inc. stock logo
EAR
Eargo
$70.50
$52.85
$1.47
$8.48
$1.46B1.523,347 shsN/A
Inogen, Inc. stock logo
INGN
Inogen
$7.09
+2.0%
$7.67
$4.13
$14.10
$162.12M1.06309,611 shs346,206 shs
Vicarious Surgical Inc stock logo
RBOT
Vicarious Surgical
$0.29
+3.6%
$0.34
$0.20
$2.46
$48.68M1.18543,116 shs211,198 shs
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
$34.01
+7.6%
$36.43
$26.06
$48.66
$272.48M1.5712,995 shs24,249 shs
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cadre Holdings, Inc. stock logo
CDRE
Cadre
-0.48%-3.54%-6.15%-2.08%+48.45%
Eargo, Inc. stock logo
EAR
Eargo
0.00%0.00%0.00%+2,550.38%+1,210.41%
Inogen, Inc. stock logo
INGN
Inogen
+2.01%-2.61%+3.50%+32.52%-45.46%
Vicarious Surgical Inc stock logo
RBOT
Vicarious Surgical
+2.72%-8.03%-18.51%-38.19%-87.22%
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
+7.63%+3.22%-8.67%-7.81%-27.91%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cadre Holdings, Inc. stock logo
CDRE
Cadre
4.1169 of 5 stars
4.32.02.50.01.53.31.9
Eargo, Inc. stock logo
EAR
Eargo
N/AN/AN/AN/AN/AN/AN/AN/A
Inogen, Inc. stock logo
INGN
Inogen
4.1494 of 5 stars
3.04.00.03.92.81.71.3
Vicarious Surgical Inc stock logo
RBOT
Vicarious Surgical
0.9397 of 5 stars
3.02.00.00.00.02.50.6
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
1.4485 of 5 stars
3.52.00.00.02.41.70.0

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cadre Holdings, Inc. stock logo
CDRE
Cadre
2.60
Moderate Buy$41.2525.11% Upside
Eargo, Inc. stock logo
EAR
Eargo
N/AN/AN/AN/A
Inogen, Inc. stock logo
INGN
Inogen
2.00
Hold$13.6792.76% Upside
Vicarious Surgical Inc stock logo
RBOT
Vicarious Surgical
2.00
Hold$0.67131.88% Upside
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
3.00
Buy$44.0029.37% Upside

Current Analyst Ratings

Latest INGN, CDRE, RBOT, EAR, and SMTI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/9/2024
Inogen, Inc. stock logo
INGN
Inogen
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
3/27/2024
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$49.00 ➝ $44.00
3/6/2024
Cadre Holdings, Inc. stock logo
CDRE
Cadre
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$38.00 ➝ $43.00
3/6/2024
Cadre Holdings, Inc. stock logo
CDRE
Cadre
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$33.00 ➝ $34.00
3/6/2024
Cadre Holdings, Inc. stock logo
CDRE
Cadre
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$40.00 ➝ $48.00
3/5/2024
Vicarious Surgical Inc stock logo
RBOT
Vicarious Surgical
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$1.50 ➝ $1.00
2/21/2024
Cadre Holdings, Inc. stock logo
CDRE
Cadre
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy$32.00 ➝ $38.00
2/16/2024
Cadre Holdings, Inc. stock logo
CDRE
Cadre
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$36.00 ➝ $40.00
2/15/2024
Inogen, Inc. stock logo
INGN
Inogen
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform
2/6/2024
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$49.00
1/22/2024
Cadre Holdings, Inc. stock logo
CDRE
Cadre
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$482.53M2.57$1.50 per share21.98$5.25 per share6.28
Eargo, Inc. stock logo
EAR
Eargo
$41.11M35.61N/AN/A$4.87 per share14.48
Inogen, Inc. stock logo
INGN
Inogen
$315.66M0.52N/AN/A$8.79 per share0.81
Vicarious Surgical Inc stock logo
RBOT
Vicarious Surgical
N/AN/AN/AN/A$0.56 per shareN/A
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
$64.99M4.51N/AN/A$5.22 per share6.52

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$38.64M$1.0232.3224.791.778.01%21.85%9.82%5/14/2024 (Estimated)
Eargo, Inc. stock logo
EAR
Eargo
-$157.49M-$7.52N/AN/A-263.14%-135.08%-96.37%N/A
Inogen, Inc. stock logo
INGN
Inogen
-$102.45M-$4.41N/AN/AN/A-32.46%-38.98%-27.03%5/7/2024 (Confirmed)
Vicarious Surgical Inc stock logo
RBOT
Vicarious Surgical
-$71.07M-$0.49N/AN/AN/AN/A-82.61%-63.88%4/29/2024 (Confirmed)
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
-$4.30M-$0.52N/AN/A-6.62%-11.12%-7.11%5/20/2024 (Estimated)

Latest INGN, CDRE, RBOT, EAR, and SMTI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
Inogen, Inc. stock logo
INGN
Inogen
-$0.76N/A+$0.76N/AN/AN/A  
4/29/2024N/A
Vicarious Surgical Inc stock logo
RBOT
Vicarious Surgical
-$0.10N/A+$0.10N/AN/AN/A  
3/25/2024Q4 2023
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
N/A-$0.03-$0.03-$0.03N/A$17.69 million
3/5/2024Q4 2023
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.18$0.29+$0.11$0.33$122.30 million$124.58 million
3/4/202412/31/2023
Vicarious Surgical Inc stock logo
RBOT
Vicarious Surgical
-$0.12-$0.07+$0.05-$0.08N/AN/A    
2/27/2024Q4 2023
Inogen, Inc. stock logo
INGN
Inogen
-$0.65-$1.14-$0.49-$1.14$78.09 million$75.90 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.351.06%N/A34.31%1 Years
Eargo, Inc. stock logo
EAR
Eargo
N/AN/AN/AN/AN/A
Inogen, Inc. stock logo
INGN
Inogen
N/AN/AN/AN/AN/A
Vicarious Surgical Inc stock logo
RBOT
Vicarious Surgical
N/AN/AN/AN/AN/A
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
N/AN/AN/AN/AN/A

Latest INGN, CDRE, RBOT, EAR, and SMTI Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/23/2024
Cadre Holdings, Inc. stock logo
CDRE
Cadre
quarterly$0.08751.07%2/1/20242/2/20242/16/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cadre Holdings, Inc. stock logo
CDRE
Cadre
0.65
2.58
1.73
Eargo, Inc. stock logo
EAR
Eargo
N/A
3.22
2.97
Inogen, Inc. stock logo
INGN
Inogen
N/A
2.86
2.55
Vicarious Surgical Inc stock logo
RBOT
Vicarious Surgical
N/A
13.87
13.87
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
0.20
1.38
1.04

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Cadre Holdings, Inc. stock logo
CDRE
Cadre
43.95%
Eargo, Inc. stock logo
EAR
Eargo
80.53%
Inogen, Inc. stock logo
INGN
Inogen
89.94%
Vicarious Surgical Inc stock logo
RBOT
Vicarious Surgical
47.27%
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
8.10%

Insider Ownership

CompanyInsider Ownership
Cadre Holdings, Inc. stock logo
CDRE
Cadre
49.20%
Eargo, Inc. stock logo
EAR
Eargo
0.81%
Inogen, Inc. stock logo
INGN
Inogen
0.64%
Vicarious Surgical Inc stock logo
RBOT
Vicarious Surgical
14.73%
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
55.20%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Cadre Holdings, Inc. stock logo
CDRE
Cadre
2,43537.59 million19.09 millionOptionable
Eargo, Inc. stock logo
EAR
Eargo
24320.76 million20.59 millionNot Optionable
Inogen, Inc. stock logo
INGN
Inogen
83423.33 million23.18 millionOptionable
Vicarious Surgical Inc stock logo
RBOT
Vicarious Surgical
3175.75 million149.86 millionOptionable
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
1078.62 million3.86 millionNot Optionable

INGN, CDRE, RBOT, EAR, and SMTI Headlines

SourceHeadline
Sanara MedTech Inc. Announces $55 Million Debt FacilitySanara MedTech Inc. Announces $55 Million Debt Facility
globenewswire.com - April 18 at 9:15 AM
Sanara MedTech (NASDAQ:SMTI)  Shares Down 0.2% Sanara MedTech (NASDAQ:SMTI) Shares Down 0.2%
marketbeat.com - April 18 at 12:40 AM
Sanara Medtech Inc (SMTI)Sanara Medtech Inc (SMTI)
investing.com - April 11 at 7:36 AM
Sanara MedTech Names Jake Waldrop COO, Effective April 15; Stock Up In Pre-marketSanara MedTech Names Jake Waldrop COO, Effective April 15; Stock Up In Pre-market
markets.businessinsider.com - April 5 at 10:14 AM
Sanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy OfficerSanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy Officer
globenewswire.com - April 5 at 9:00 AM
Sanara MedTech Inc. (NASDAQ:SMTI) Q4 2023 Earnings Call TranscriptSanara MedTech Inc. (NASDAQ:SMTI) Q4 2023 Earnings Call Transcript
finance.yahoo.com - March 29 at 9:57 AM
Sanara MedTech Inc. (SMTI) Q4 2023 Earnings Call TranscriptSanara MedTech Inc. (SMTI) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 28 at 1:54 PM
Cantor Fitzgerald Trims Sanara MedTech (NASDAQ:SMTI) Target Price to $44.00Cantor Fitzgerald Trims Sanara MedTech (NASDAQ:SMTI) Target Price to $44.00
marketbeat.com - March 27 at 10:15 AM
SMTI Stock Earnings: Sanara MedTech Beats EPS, Beats Revenue for Q4 2023SMTI Stock Earnings: Sanara MedTech Beats EPS, Beats Revenue for Q4 2023
investorplace.com - March 25 at 9:39 PM
Sanara MedTech Inc (SMTI) Reports Strong Sales Growth and Reduced Net Loss for Full Year 2023Sanara MedTech Inc (SMTI) Reports Strong Sales Growth and Reduced Net Loss for Full Year 2023
finance.yahoo.com - March 25 at 7:09 PM
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 ResultsSanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results
globenewswire.com - March 25 at 4:05 PM
Sanara MedTechs Earnings: A PreviewSanara MedTech's Earnings: A Preview
benzinga.com - March 22 at 4:38 PM
Investors in Sanara MedTech (NASDAQ:SMTI) have seen fantastic returns of 541% over the past five yearsInvestors in Sanara MedTech (NASDAQ:SMTI) have seen fantastic returns of 541% over the past five years
finance.yahoo.com - March 13 at 12:55 PM
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call DatesSanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Dates
globenewswire.com - March 13 at 9:15 AM
Cyient partners with MassMedic to accelerate MedTech innovationCyient partners with MassMedic to accelerate MedTech innovation
pharmabiz.com - March 6 at 6:08 PM
CGI Cellerate RX, LLCs Net WorthCGI Cellerate RX, LLC's Net Worth
benzinga.com - March 6 at 6:08 PM
Sanara MedTech Stock (NASDAQ:SMTI), Analyst Ratings, Price Targets, PredictionsSanara MedTech Stock (NASDAQ:SMTI), Analyst Ratings, Price Targets, Predictions
benzinga.com - February 23 at 2:58 AM
Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023
globenewswire.com - February 22 at 9:15 AM
Sanara MedTech Inc. (NASDAQ:SMTI) About To Shift From Loss To ProfitSanara MedTech Inc. (NASDAQ:SMTI) About To Shift From Loss To Profit
finance.yahoo.com - January 5 at 8:20 AM
Sanara MedTech announces exclusive license agreement for patented collagen peptidesSanara MedTech announces exclusive license agreement for patented collagen peptides
msn.com - January 3 at 1:43 PM
Sanara MedTech Inks Exclusive License Agreement With Tufts UniversitySanara MedTech Inks Exclusive License Agreement With Tufts University
markets.businessinsider.com - January 3 at 1:43 PM
Sanara MedTech Inc. Announces Exclusive License Agreement for Patented Collagen PeptidesSanara MedTech Inc. Announces Exclusive License Agreement for Patented Collagen Peptides
finance.yahoo.com - January 3 at 1:43 PM
Sanara MedTech Inc.s (NASDAQ:SMTI) top owners are retail investors with 32% stake, while 31% is held by insidersSanara MedTech Inc.'s (NASDAQ:SMTI) top owners are retail investors with 32% stake, while 31% is held by insiders
finance.yahoo.com - December 4 at 1:18 PM
Sanara MedTech Inc. Announces the Publication of a 5,335 Patient Study Demonstrating a Significant Reduction in Surgical Site Infections When Activated Collagen (CellerateRX® Surgical Powder) Was Used to Promote Wound HealingSanara MedTech Inc. Announces the Publication of a 5,335 Patient Study Demonstrating a Significant Reduction in Surgical Site Infections When Activated Collagen (CellerateRX® Surgical Powder) Was Used to Promote Wound Healing
finance.yahoo.com - November 30 at 12:37 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Cadre logo

Cadre

NYSE:CDRE
Cadre Holdings, Inc. manufactures and distributes safety that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products. The company also offers third-party products, such as uniforms, optics, boots, firearms, and ammunition. It serves first responders, such as state and local law enforcement, fire and rescue, explosive ordnance disposal technicians, emergency medical technicians, fishing, and wildlife enforcement and departments of corrections, as well as federal agencies including the U.S. Department of State, U.S. Department of Defense, U.S. Department of Interior, U.S. Department of Justice, U.S. Department of Homeland Security, U.S. Department of Corrections, the Department of Energy, Los Alamos National Laboratories, Waste Isolation Plant, and various foreign government agencies. Cadre Holdings, Inc. was founded in 1964 and is headquartered in Jacksonville, Florida.
Eargo logo

Eargo

NASDAQ:EAR
Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. It markets and sells hearing aids. The company sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was incorporated in 2010 and is headquartered in San Jose, California.
Inogen logo

Inogen

NASDAQ:INGN
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Vicarious Surgical logo

Vicarious Surgical

NYSE:RBOT
Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Sanara MedTech logo

Sanara MedTech

NASDAQ:SMTI
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.